IntelliCell BioSciences has inked an exclusive distribution and sale deal with Millipore to supply and sell Millipore’s guava flow cytometry system into the field of stromal vascular fraction (SVF).
This partnership will support the growth of the tissue processing centers of IntelliCell, as demand for the cells sourced from fatty tissue is continuously growing. The application of autologous adipose (fat) stem cells for several indications is a promising field in medicine. Autologous adipose stem cells have been widely utilized in the aesthetics market in Asia and Europe. After the publication of regulations on autologous stem cells by the US FDA in 2009, the field has experienced a rapid growth.
At present, several researchers, manufacturers and doctors have been investigating the application of adipose stem cells for congestive heart failure; wound healing; gum regeneration; orthopedic injuries in shoulders, back, elbows and knees; arthritis treatment; aesthetics and more. Moreover, various studies for veterinary applications have been experimented on animals for the past several years.
Dr. Steven Victor, Chairman and Chief Executive Officer at IntelliCell BioSciences, stated that the exclusive deal to distribute and sell Millipore’s advanced guava flow cytometer in combination with IntelliCell BioSciences’ proprietary process, which has obtained record stromal vascular fraction yields while eliminating the application of chemical additives like enzymes, offers an important advantage in setting the benchmark for the isolation of SVF from fat.
Source: http://www.intellicellbiosciences.com